Pharmacare Act  Mr. Speaker, my colleague from Thunder Bay—Rainy River is always thoughtful here and mindful of the shortfalls of things the government puts forward. There are a couple of things, though, to think about. At the health committee, we had two of Canada's experts, Drs. Morgan and Gagnon, and as the member well knows, they had no input into but much criticism about this bill.

Pharmacare Act  Mr. Speaker, with respect to all Canadians such as physicians, nurse practitioners and pharmacists who are listening and who are out there prescribing medications this evening, I find it fascinating that the member would be suggesting that their appropriateness is actually inappropriate and that we need the government now to tell physicians what to prescribe.

Pharmacare Act  Madam Speaker, it is absolutely fascinating, because when we look at the statistics, about a million people really do suffer from a lack of coverage. That is just the fact, in spite of the conflated numbers that the member from NDP wishes to state. Maybe the member could do his math again on behalf of all Canadians and let Canadians know how many diabetics really need this program.

Pharmacare Act  Madam Speaker, sometimes people liken getting a group of doctors angry to getting a bunch of bees angry, in the sense that if we make one mad, they all want to sting us. That interesting image would hold true in this case. How do we decide things when a group of experts get in a room?

Pharmacare Act  Madam Speaker, it is very important to respect provincial jurisdictions. Everyone in the House knows that the province of Quebec has a drug coverage program. It is a very extensive program, but it costs too much. We need to sit down together, talk about the problems and find solutions, especially in a case like this, where drug coverage is really a provincial responsibility.

Pharmacare Act  Madam Speaker, let us be clear. I do not fear anything the NDP members have to say or think. I think that is important. They fear spending money on anything except democracy. All they want to do is ram legislation through, in their costly coalition partnership, with respect to things they sadly do not understand.

Pharmacare Act  moved: Motion No. 1 That Bill C-64 be amended by deleting the short title Motion No. 2 That Bill C-64 be amended by deleting Clause 2. Motion No. 3 That Bill C-64 be amended by deleting Clause 3. Motion No. 4 That Bill C-64 be amended by deleting Clause 4.

Pharmacare Act  Madam Speaker, it is interesting here in the House, the whole idea, whether the NDP-Liberal costly coalition likes it or not, of actually having a robust debate, especially when there are significant differences of opinion. Of course, that is why we are here tonight. We on this side of the House believe that legislation should be debated, and debated robustly, in spite of the fact of the trickery and antics used by the costly coalition to move closure on the bill.

Mental Health and Addictions  Mr. Speaker, last night, the Minister of Mental Health and Addictions said that the Prime Minister's deadly experiment of hard drug legalization in B.C. was a success. After nine years of the NDP-Liberal Prime Minister, drug overdose deaths are up 380% in B.C. The minister refused to rule out expanding the drug legalization in Toronto, or Montreal or anywhere else in Canada.

Business of Supply  Madam Chair, that is not what I asked, but “legally possess, produce, sell and distribute opium and heroin in Canada”, were the words. Yes or no.

Business of Supply  Madam Chair, Canadians should know that Sunshine Earth Labs was granted such a dealer's licence in January 2023. Has any private firm been licensed to legally produce, sell or distribute cocaine in Canada?

Business of Supply  Madam Chair, that is absolutely untrue. Sunshine Earth Labs was granted a license in November 2022. How about Ecstasy?

Business of Supply  Madam Chair, that is untrue. In January 2024, they were allowed to manufacture up to 20 kilograms of Ecstasy. How many applications for a dealer's licence are currently pending?

Business of Supply  Madam Chair, would the minister reject further licences for MDMA, or Ecstasy, cocaine and heroin?

Business of Supply  Minister, when did your government fully commit to so-called—